Vancomycin Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Vancomycin Hydrochloride Price Trend, Index and Forecast
Track the latest insights on vancomycin hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Vancomycin Hydrochloride Prices Outlook Q3 2025
- USA: USD 698975/MT
- China: USD 627594/MT
- Germany: USD 680124/MT
- Brazil: USD 617588/MT
- India: USD 620500/MT
Vancomycin Hydrochloride Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the vancomycin hydrochloride prices in the USA reached 698975 USD/MT in September. Prices moved upward as demand from hospital procurement channels and injectable antibiotic formulations increased. Higher usage in critical care settings supported offtake. Buyers advanced sourcing to ensure supply continuity, while regulated manufacturing capacity influenced procurement planning.
During the third quarter of 2025, the vancomycin hydrochloride prices in China reached 627594 USD/MT in September. Prices declined due to moderated demand from export-oriented pharmaceutical manufacturers. Softer overseas orders and sufficient domestic production availability influenced cautious procurement. Buyers focused on inventory optimization rather than forward purchases.
During the third quarter of 2025, the vancomycin hydrochloride prices in Germany reached 680124 USD/MT in September. Prices increased as demand from hospital supply chains and pharmaceutical formulations strengthened. Usage in injectable antibiotics supported consumption. Buyers emphasized securing compliant material aligned with regulatory and quality standards.
During the third quarter of 2025, the vancomycin hydrochloride prices in Brazil reached 617588 USD/MT in September. Prices moved downward amid reduced hospital procurement and controlled public healthcare purchasing. Adequate import availability and inventory levels influenced restrained sourcing activity.
During the third quarter of 2025, the vancomycin hydrochloride prices in India reached 620500 USD/MT in September. Prices increased due to rising demand from domestic pharmaceutical formulation and export-oriented API usage. Buyers secured material to meet manufacturing commitments, while regulated production capacity shaped sourcing strategies.
Vancomycin Hydrochloride Prices Outlook Q2 2025
- USA: USD 675338/MT
- Germany: USD 659674/MT
- China: USD 638448/MT
- Brazil: USD 644664/MT
- India: USD 605336/MT
During the second quarter of 2025, the vancomycin hydrochloride prices in the USA reached 675338 USD/MT in June. Prices moved downward as hospital procurement volumes softened and distributors relied on existing inventories. Buyers limited new purchases while aligning sourcing with confirmed medical demand.
During the second quarter of 2025, the vancomycin hydrochloride prices in Germany reached 659674 USD/MT in June. Prices declined due to controlled purchasing by healthcare systems and moderated pharmaceutical offtake. Buyers focused on contract-based procurement and inventory management.
During the second quarter of 2025, the vancomycin hydrochloride prices in China reached 638448 USD/MT in June. Prices moved lower as export demand weakened and domestic availability remained sufficient. Pharmaceutical manufacturers adjusted procurement volumes to align with reduced order visibility.
During the second quarter of 2025, the vancomycin hydrochloride prices in Brazil reached 644664 USD/MT in June. Prices declined amid slower public healthcare procurement and cautious distributor purchasing. Import availability supported supply without increasing sourcing urgency.
During the second quarter of 2025, the vancomycin hydrochloride prices in India reached 605336 USD/MT in June. Demand from pharmaceutical formulation and regulated exports influenced procurement activity. Buyers aligned sourcing with production schedules and compliance requirements.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the vancomycin hydrochloride prices.
Europe Vancomycin Hydrochloride Price Trend
Q3 2025:
As per the vancomycin hydrochloride price index, Europe experienced upward price movement, led by increases in Germany. Demand from hospital procurement systems and injectable antibiotic manufacturing supported consumption. German pharmaceutical producers increased sourcing to meet regulated healthcare requirements. Strict quality standards and compliance protocols influenced supplier selection. Regional production capacity and controlled imports shaped availability, while buyers aligned procurement with hospital tenders and pharmaceutical formulation schedules.
Q2 2025:
Europe experienced downward price movement, driven by declines in Germany. Controlled healthcare spending and reduced hospital purchasing volumes influenced demand. Buyers relied on existing inventories and contract-based sourcing. Regulatory compliance and quality assurance remained central to procurement decisions. Regional availability supported disciplined purchasing aligned with confirmed medical requirements.
This analysis can be extended to include detailed vancomycin hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Vancomycin Hydrochloride Price Trend
Q3 2025:
As per the vancomycin hydrochloride price index, North America experienced upward price movement, supported by increases in the USA. Rising hospital demand for injectable antibiotics and critical care usage strengthened consumption. Buyers advanced procurement to ensure uninterrupted supply. Regulated manufacturing capacity and distribution controls influenced sourcing strategies aligned with healthcare system requirements.
Q2 2025:
North America experienced downward price movement, led by declines in the USA. Softer hospital procurement and distributor inventory drawdowns reduced purchasing activity. Buyers focused on aligning sourcing with immediate medical demand. Domestic availability and regulatory distribution frameworks supported supply continuity.
Specific data on vancomycin hydrochloride prices within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Vancomycin Hydrochloride Price Trend
Q3 2025:
As per vancomycin hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the vancomycin hydrochloride pricing trends and vancomycin hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on vancomycin hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Vancomycin Hydrochloride Price Trend
Q3 2025:
Asia Pacific exhibited mixed pricing dynamics, with upward movement in India and downward pressure in China. Divergent demand trends between domestic pharmaceutical formulation and export-oriented manufacturing shaped consumption. Buyers adjusted sourcing strategies based on country-specific demand visibility. Domestic production capacity and regulated supply chains influenced procurement planning aligned with pharmaceutical manufacturing schedules.
Q2 2025:
As per the vancomycin hydrochloride price index, Asia Pacific experienced downward price movement, driven by declines in China. Reduced export demand and sufficient domestic availability influenced regional sourcing behavior. Buyers coordinated procurement with production planning and inventory management. Regulatory compliance and quality considerations guided purchasing decisions across key manufacturing hubs.
This analysis can be further extended to include detailed vancomycin hydrochloride prices for a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Vancomycin Hydrochloride Price Trend
Q3 2025:
Vancomycin hydrochloride prices in Latin America moved downward, led by declines in Brazil. Reduced public healthcare procurement and cautious distributor purchasing softened demand. Import availability supported supply, limiting procurement urgency. Buyers focused on aligning purchases with confirmed hospital requirements and inventory positions.
Q2 2025:
As per the vancomycin hydrochloride price index, Latin America experienced downward price movement, shaped by declines in Brazil. Controlled healthcare spending and moderated hospital demand influenced procurement volumes. Buyers emphasized inventory management and contract-based sourcing aligned with medical usage requirements.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Vancomycin Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Vancomycin Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the vancomycin hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of vancomycin hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed vancomycin hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting vancomycin hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Vancomycin Hydrochloride Industry Analysis
The global vancomycin hydrochloride industry size reached USD 795.8 Million in 2025. By 2034, IMARC Group expects the market to reach USD 1,101.8 Million, at a projected CAGR of 3.68% during 2026-2034. Market growth is driven by sustained demand for injectable antibiotics, rising incidence of resistant bacterial infections, expanding hospital infrastructure, and continued reliance on vancomycin hydrochloride in critical care and regulated pharmaceutical applications worldwide.
Latest News and Developments:
- April 2025: Glenmark Pharmaceuticals Inc., USA, launched Vancomycin Hydrochloride for Injection USP in the United States in three single-dose vial strengths (750 mg, 1.25 g and 1.5 g), marking an expansion of its institutional injectable antibiotic portfolio. The product is bioequivalent and therapeutically equivalent to the reference listed vancomycin hydrochloride drug.
Product Description
Vancomycin hydrochloride, a glycopeptide class antibiotic, is utilized to treat serious bacterial infections, particularly those caused by Gram-positive bacteria resistant to other antibiotics. Its complicated configuration enables it to hinder the formation of bacterial cell walls, thus preventing the proliferation and replication of bacteria. Vancomycin is produced through a fermentation method involving a specific bacterium called Amycolatopsis orientalis. Following the fermentation process, the compound is extracted and subsequently purified.
Additional chemical processes ensure its transformation into a hydrochloride salt form, which enhances some of its properties, including its solubility, and hence its stability, and is why it is used in a medical context both in injectable and oral forms. It is highly efficient in treating certain infections, like those resulting from methicillin-resistant Staphylococcus aureus, and is viewed as a final option medication for specific bacterial pneumonia, septicemia, and endocarditis cases.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Vancomycin Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of vancomycin hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting vancomycin hydrochloride price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the vancomycin hydrochloride industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.